Global Long-Acting Injectables Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Long-Acting Injectables market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Long-Acting Injectables market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Schizophrenia accounting for % of the Long-Acting Injectables global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Small and Middle Sized Molecule segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Long-Acting Injectables include Eli Lilly, Pfizer, GlaxoSmithKline, Johnson & Johnson, and Lupin, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Long-Acting Injectables market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Small and Middle Sized Molecule
Large Sized Molecule
Market segment by Application, can be divided into
Schizophrenia
Other Psychotic Disorders
Market segment by players, this report covers
Eli Lilly
Pfizer
GlaxoSmithKline
Johnson & Johnson
Lupin
Zogenix
DURECT
Medincel
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Long-Acting Injectables product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Long-Acting Injectables, with revenue, gross margin and global market share of Long-Acting Injectables from 2019 to 2022.
Chapter 3, the Long-Acting Injectables competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Long-Acting Injectables market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Long-Acting Injectables research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Long-Acting Injectables
1.2 Classification of Long-Acting Injectables by Type
1.2.1 Overview: Global Long-Acting Injectables Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Long-Acting Injectables Revenue Market Share by Type in 2021
1.2.3 Small and Middle Sized Molecule
1.2.4 Large Sized Molecule
1.3 Global Long-Acting Injectables Market by Application
1.3.1 Overview: Global Long-Acting Injectables Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Schizophrenia
1.3.3 Other Psychotic Disorders
1.4 Global Long-Acting Injectables Market Size & Forecast
1.5 Global Long-Acting Injectables Market Size and Forecast by Region
1.5.1 Global Long-Acting Injectables Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Long-Acting Injectables Market Size by Region, (2017-2022)
1.5.3 North America Long-Acting Injectables Market Size and Prospect (2017-2028)
1.5.4 Europe Long-Acting Injectables Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Long-Acting Injectables Market Size and Prospect (2017-2028)
1.5.6 South America Long-Acting Injectables Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Long-Acting Injectables Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Long-Acting Injectables Market Drivers
1.6.2 Long-Acting Injectables Market Restraints
1.6.3 Long-Acting Injectables Trends Analysis
2 Company Profiles
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business
2.1.3 Eli Lilly Long-Acting Injectables Product and Solutions
2.1.4 Eli Lilly Long-Acting Injectables Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Eli Lilly Recent Developments and Future Plans
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Long-Acting Injectables Product and Solutions
2.2.4 Pfizer Long-Acting Injectables Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Pfizer Recent Developments and Future Plans
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Long-Acting Injectables Product and Solutions
2.3.4 GlaxoSmithKline Long-Acting Injectables Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 GlaxoSmithKline Recent Developments and Future Plans
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Long-Acting Injectables Product and Solutions
2.4.4 Johnson & Johnson Long-Acting Injectables Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Johnson & Johnson Recent Developments and Future Plans
2.5 Lupin
2.5.1 Lupin Details
2.5.2 Lupin Major Business
2.5.3 Lupin Long-Acting Injectables Product and Solutions
2.5.4 Lupin Long-Acting Injectables Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Lupin Recent Developments and Future Plans
2.6 Zogenix
2.6.1 Zogenix Details
2.6.2 Zogenix Major Business
2.6.3 Zogenix Long-Acting Injectables Product and Solutions
2.6.4 Zogenix Long-Acting Injectables Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Zogenix Recent Developments and Future Plans
2.7 DURECT
2.7.1 DURECT Details
2.7.2 DURECT Major Business
2.7.3 DURECT Long-Acting Injectables Product and Solutions
2.7.4 DURECT Long-Acting Injectables Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 DURECT Recent Developments and Future Plans
2.8 Medincel
2.8.1 Medincel Details
2.8.2 Medincel Major Business
2.8.3 Medincel Long-Acting Injectables Product and Solutions
2.8.4 Medincel Long-Acting Injectables Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Medincel Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Long-Acting Injectables Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Long-Acting Injectables Players Market Share in 2021
3.2.2 Top 10 Long-Acting Injectables Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Long-Acting Injectables Players Head Office, Products and Services Provided
3.4 Long-Acting Injectables Mergers & Acquisitions
3.5 Long-Acting Injectables New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Long-Acting Injectables Revenue and Market Share by Type (2017-2022)
4.2 Global Long-Acting Injectables Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Long-Acting Injectables Revenue Market Share by Application (2017-2022)
5.2 Global Long-Acting Injectables Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Long-Acting Injectables Revenue by Type (2017-2028)
6.2 North America Long-Acting Injectables Revenue by Application (2017-2028)
6.3 North America Long-Acting Injectables Market Size by Country
6.3.1 North America Long-Acting Injectables Revenue by Country (2017-2028)
6.3.2 United States Long-Acting Injectables Market Size and Forecast (2017-2028)
6.3.3 Canada Long-Acting Injectables Market Size and Forecast (2017-2028)
6.3.4 Mexico Long-Acting Injectables Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Long-Acting Injectables Revenue by Type (2017-2028)
7.2 Europe Long-Acting Injectables Revenue by Application (2017-2028)
7.3 Europe Long-Acting Injectables Market Size by Country
7.3.1 Europe Long-Acting Injectables Revenue by Country (2017-2028)
7.3.2 Germany Long-Acting Injectables Market Size and Forecast (2017-2028)
7.3.3 France Long-Acting Injectables Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Long-Acting Injectables Market Size and Forecast (2017-2028)
7.3.5 Russia Long-Acting Injectables Market Size and Forecast (2017-2028)
7.3.6 Italy Long-Acting Injectables Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Long-Acting Injectables Revenue by Type (2017-2028)
8.2 Asia-Pacific Long-Acting Injectables Revenue by Application (2017-2028)
8.3 Asia-Pacific Long-Acting Injectables Market Size by Region
8.3.1 Asia-Pacific Long-Acting Injectables Revenue by Region (2017-2028)
8.3.2 China Long-Acting Injectables Market Size and Forecast (2017-2028)
8.3.3 Japan Long-Acting Injectables Market Size and Forecast (2017-2028)
8.3.4 South Korea Long-Acting Injectables Market Size and Forecast (2017-2028)
8.3.5 India Long-Acting Injectables Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Long-Acting Injectables Market Size and Forecast (2017-2028)
8.3.7 Australia Long-Acting Injectables Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Long-Acting Injectables Revenue by Type (2017-2028)
9.2 South America Long-Acting Injectables Revenue by Application (2017-2028)
9.3 South America Long-Acting Injectables Market Size by Country
9.3.1 South America Long-Acting Injectables Revenue by Country (2017-2028)
9.3.2 Brazil Long-Acting Injectables Market Size and Forecast (2017-2028)
9.3.3 Argentina Long-Acting Injectables Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Long-Acting Injectables Revenue by Type (2017-2028)
10.2 Middle East & Africa Long-Acting Injectables Revenue by Application (2017-2028)
10.3 Middle East & Africa Long-Acting Injectables Market Size by Country
10.3.1 Middle East & Africa Long-Acting Injectables Revenue by Country (2017-2028)
10.3.2 Turkey Long-Acting Injectables Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Long-Acting Injectables Market Size and Forecast (2017-2028)
10.3.4 UAE Long-Acting Injectables Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Long-Acting Injectables Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Long-Acting Injectables Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Long-Acting Injectables Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Long-Acting Injectables Revenue (USD Million) by Region (2017-2022)
Table 5. Global Long-Acting Injectables Revenue Market Share by Region (2023-2028)
Table 6. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 7. Eli Lilly Major Business
Table 8. Eli Lilly Long-Acting Injectables Product and Solutions
Table 9. Eli Lilly Long-Acting Injectables Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Pfizer Corporate Information, Head Office, and Major Competitors
Table 11. Pfizer Major Business
Table 12. Pfizer Long-Acting Injectables Product and Solutions
Table 13. Pfizer Long-Acting Injectables Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 15. GlaxoSmithKline Major Business
Table 16. GlaxoSmithKline Long-Acting Injectables Product and Solutions
Table 17. GlaxoSmithKline Long-Acting Injectables Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 19. Johnson & Johnson Major Business
Table 20. Johnson & Johnson Long-Acting Injectables Product and Solutions
Table 21. Johnson & Johnson Long-Acting Injectables Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Lupin Corporate Information, Head Office, and Major Competitors
Table 23. Lupin Major Business
Table 24. Lupin Long-Acting Injectables Product and Solutions
Table 25. Lupin Long-Acting Injectables Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Zogenix Corporate Information, Head Office, and Major Competitors
Table 27. Zogenix Major Business
Table 28. Zogenix Long-Acting Injectables Product and Solutions
Table 29. Zogenix Long-Acting Injectables Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. DURECT Corporate Information, Head Office, and Major Competitors
Table 31. DURECT Major Business
Table 32. DURECT Long-Acting Injectables Product and Solutions
Table 33. DURECT Long-Acting Injectables Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Medincel Corporate Information, Head Office, and Major Competitors
Table 35. Medincel Major Business
Table 36. Medincel Long-Acting Injectables Product and Solutions
Table 37. Medincel Long-Acting Injectables Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Global Long-Acting Injectables Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 39. Global Long-Acting Injectables Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 40. Breakdown of Long-Acting Injectables by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. Long-Acting Injectables Players Head Office, Products and Services Provided
Table 42. Long-Acting Injectables Mergers & Acquisitions in the Past Five Years
Table 43. Long-Acting Injectables New Entrants and Expansion Plans
Table 44. Global Long-Acting Injectables Revenue (USD Million) by Type (2017-2022)
Table 45. Global Long-Acting Injectables Revenue Share by Type (2017-2022)
Table 46. Global Long-Acting Injectables Revenue Forecast by Type (2023-2028)
Table 47. Global Long-Acting Injectables Revenue by Application (2017-2022)
Table 48. Global Long-Acting Injectables Revenue Forecast by Application (2023-2028)
Table 49. North America Long-Acting Injectables Revenue by Type (2017-2022) & (USD Million)
Table 50. North America Long-Acting Injectables Revenue by Type (2023-2028) & (USD Million)
Table 51. North America Long-Acting Injectables Revenue by Application (2017-2022) & (USD Million)
Table 52. North America Long-Acting Injectables Revenue by Application (2023-2028) & (USD Million)
Table 53. North America Long-Acting Injectables Revenue by Country (2017-2022) & (USD Million)
Table 54. North America Long-Acting Injectables Revenue by Country (2023-2028) & (USD Million)
Table 55. Europe Long-Acting Injectables Revenue by Type (2017-2022) & (USD Million)
Table 56. Europe Long-Acting Injectables Revenue by Type (2023-2028) & (USD Million)
Table 57. Europe Long-Acting Injectables Revenue by Application (2017-2022) & (USD Million)
Table 58. Europe Long-Acting Injectables Revenue by Application (2023-2028) & (USD Million)
Table 59. Europe Long-Acting Injectables Revenue by Country (2017-2022) & (USD Million)
Table 60. Europe Long-Acting Injectables Revenue by Country (2023-2028) & (USD Million)
Table 61. Asia-Pacific Long-Acting Injectables Revenue by Type (2017-2022) & (USD Million)
Table 62. Asia-Pacific Long-Acting Injectables Revenue by Type (2023-2028) & (USD Million)
Table 63. Asia-Pacific Long-Acting Injectables Revenue by Application (2017-2022) & (USD Million)
Table 64. Asia-Pacific Long-Acting Injectables Revenue by Application (2023-2028) & (USD Million)
Table 65. Asia-Pacific Long-Acting Injectables Revenue by Region (2017-2022) & (USD Million)
Table 66. Asia-Pacific Long-Acting Injectables Revenue by Region (2023-2028) & (USD Million)
Table 67. South America Long-Acting Injectables Revenue by Type (2017-2022) & (USD Million)
Table 68. South America Long-Acting Injectables Revenue by Type (2023-2028) & (USD Million)
Table 69. South America Long-Acting Injectables Revenue by Application (2017-2022) & (USD Million)
Table 70. South America Long-Acting Injectables Revenue by Application (2023-2028) & (USD Million)
Table 71. South America Long-Acting Injectables Revenue by Country (2017-2022) & (USD Million)
Table 72. South America Long-Acting Injectables Revenue by Country (2023-2028) & (USD Million)
Table 73. Middle East & Africa Long-Acting Injectables Revenue by Type (2017-2022) & (USD Million)
Table 74. Middle East & Africa Long-Acting Injectables Revenue by Type (2023-2028) & (USD Million)
Table 75. Middle East & Africa Long-Acting Injectables Revenue by Application (2017-2022) & (USD Million)
Table 76. Middle East & Africa Long-Acting Injectables Revenue by Application (2023-2028) & (USD Million)
Table 77. Middle East & Africa Long-Acting Injectables Revenue by Country (2017-2022) & (USD Million)
Table 78. Middle East & Africa Long-Acting Injectables Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Long-Acting Injectables Picture
Figure 2. Global Long-Acting Injectables Revenue Market Share by Type in 2021
Figure 3. Small and Middle Sized Molecule
Figure 4. Large Sized Molecule
Figure 5. Long-Acting Injectables Revenue Market Share by Application in 2021
Figure 6. Schizophrenia Picture
Figure 7. Other Psychotic Disorders Picture
Figure 8. Global Long-Acting Injectables Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 9. Global Long-Acting Injectables Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Long-Acting Injectables Revenue Market Share by Region (2017-2028)
Figure 11. Global Long-Acting Injectables Revenue Market Share by Region in 2021
Figure 12. North America Long-Acting Injectables Revenue (USD Million) and Growth Rate (2017-2028)
Figure 13. Europe Long-Acting Injectables Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Asia-Pacific Long-Acting Injectables Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. South America Long-Acting Injectables Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Middle East and Africa Long-Acting Injectables Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Long-Acting Injectables Market Drivers
Figure 18. Long-Acting Injectables Market Restraints
Figure 19. Long-Acting Injectables Market Trends
Figure 20. Eli Lilly Recent Developments and Future Plans
Figure 21. Pfizer Recent Developments and Future Plans
Figure 22. GlaxoSmithKline Recent Developments and Future Plans
Figure 23. Johnson & Johnson Recent Developments and Future Plans
Figure 24. Lupin Recent Developments and Future Plans
Figure 25. Zogenix Recent Developments and Future Plans
Figure 26. DURECT Recent Developments and Future Plans
Figure 27. Medincel Recent Developments and Future Plans
Figure 28. Global Long-Acting Injectables Revenue Share by Players in 2021
Figure 29. Long-Acting Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 30. Global Top 3 Players Long-Acting Injectables Revenue Market Share in 2021
Figure 31. Global Top 10 Players Long-Acting Injectables Revenue Market Share in 2021
Figure 32. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 33. Global Long-Acting Injectables Revenue Share by Type in 2021
Figure 34. Global Long-Acting Injectables Market Share Forecast by Type (2023-2028)
Figure 35. Global Long-Acting Injectables Revenue Share by Application in 2021
Figure 36. Global Long-Acting Injectables Market Share Forecast by Application (2023-2028)
Figure 37. North America Long-Acting Injectables Sales Market Share by Type (2017-2028)
Figure 38. North America Long-Acting Injectables Sales Market Share by Application (2017-2028)
Figure 39. North America Long-Acting Injectables Revenue Market Share by Country (2017-2028)
Figure 40. United States Long-Acting Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Long-Acting Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Long-Acting Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Long-Acting Injectables Sales Market Share by Type (2017-2028)
Figure 44. Europe Long-Acting Injectables Sales Market Share by Application (2017-2028)
Figure 45. Europe Long-Acting Injectables Revenue Market Share by Country (2017-2028)
Figure 46. Germany Long-Acting Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Long-Acting Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Long-Acting Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Long-Acting Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Long-Acting Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Long-Acting Injectables Sales Market Share by Type (2017-2028)
Figure 52. Asia-Pacific Long-Acting Injectables Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Long-Acting Injectables Revenue Market Share by Region (2017-2028)
Figure 54. China Long-Acting Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Japan Long-Acting Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. South Korea Long-Acting Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. India Long-Acting Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Southeast Asia Long-Acting Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Australia Long-Acting Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. South America Long-Acting Injectables Sales Market Share by Type (2017-2028)
Figure 61. South America Long-Acting Injectables Sales Market Share by Application (2017-2028)
Figure 62. South America Long-Acting Injectables Revenue Market Share by Country (2017-2028)
Figure 63. Brazil Long-Acting Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Argentina Long-Acting Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Middle East and Africa Long-Acting Injectables Sales Market Share by Type (2017-2028)
Figure 66. Middle East and Africa Long-Acting Injectables Sales Market Share by Application (2017-2028)
Figure 67. Middle East and Africa Long-Acting Injectables Revenue Market Share by Country (2017-2028)
Figure 68. Turkey Long-Acting Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Saudi Arabia Long-Acting Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. UAE Long-Acting Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Methodology
Figure 72. Research Process and Data Source
